Cephalexin (Keflex).
D000284:Administration, Oral; D000380:Agranulocytosis / Q000139:chemically induced; D002511:Cephalosporins / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced; D004342:Drug Hypersensitivity / Q000209:etiology; D004352:Drug Resistance, Microbial; D004802:Eosinophilia / Q000139:chemically induced; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D008034:Lincomycin / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D011008:Pneumococcal Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D002511:Cephalosporins; D004917:Erythromycin; D008034:Lincomycin